Severe scalp hair loss in a female patient with acromegaly treated with lanreotide autogel after unsuccessful surgery

Cristina Alvarez-Escola; Jersy J Cárdenas-Salas; Beatriz Pelegrina; Angel Sanz-Valtierra; Beatriz Lecumberri

doi:10.1002/ccr3.388

Severe scalp hair loss in a female patient with acromegaly treated with lanreotide autogel after unsuccessful surgery

Clin Case Rep. 2015 Nov;3(11):945-8. doi: 10.1002/ccr3.388. Epub 2015 Oct 7.

Authors

Cristina Alvarez-Escola¹, Jersy J Cárdenas-Salas¹, Beatriz Pelegrina¹, Angel Sanz-Valtierra¹, Beatriz Lecumberri¹

Affiliation

¹ Endocrinology Department, La Paz University Hospital Paseo de La Castellana 261, 28046 Madrid, Spain.

Abstract

Scalp hair loss is an underreported adverse event of somatostatin analogs therapy that in severe cases may require treatment withdrawal. It can be related to an acute decrease in GH/IGF-1 levels, but a direct effect cannot be ruled out.

Keywords: Lanreotide; alopecia; hair loss; somatostatin analogs.

Publication types

Case Reports